Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I3VV
|
|||
Drug Name |
Telomelysin
|
|||
Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1] | |
Merkel cell carcinoma [ICD-11: 2C34; ICD-10: C44] | Phase 2 | [1] | ||
Company |
Oncolys Biopharma Tokyo, Japan
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.